Hao Xia

Hao Xia

Auto-generated profile, based on publicly available information

Hao Xia

Department of Cardiology Renmin Hospital of Wuhan University Wuhan China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
HXHongxia Xia
Hongxia Xia
HZHui Zhao
Hui Zhao
WYWeize Yang
Weize Yang
XLXiaomin Luo
Xiaomin Luo
JWJie Wei
Jie Wei
HXHao Xia
Hao Xia

1 June 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
YYYuan Yuan
Yuan Yuan
CXChong Xu
Chong Xu
BLBo Li
Bo Li
HXHao Xia
Hao Xia
YPYingjie Pan
Yingjie Pan
BWBin Wang
Bin Wang
CD137 (4‐1BB, tumor necrosis factor receptor superfamily 9) is a surface glycoprotein of the tumor necrosis factor receptor family that can be induced on a variety of immunocytes and nonimmune cells, including endothelial cells and smooth muscle cells. The importance of CD137 in immune response has been well recognized; however, the precise biological effects and underlying mechanisms of CD137 in endothelial cells are unclear. A single layer of cells called the endothelium constitutes the innermost layer of blood vessels including larger arteries, veins, the capillaries, and the lymphatic vessels. It not only acts as an important functional interface, but also participates in local inflammatory response. This review covers recent findings to illuminate the role of CD137 in endothelial cells in different pathophysiologic settings.